Biden administration sets nursing home staffing minimums
Apr 23, 2024
The first-ever minimum staffing rule has been set for nursing homes, the Biden administration announced Monday.
Hospital mortality lower for patients treated by female physicians
Apr 22, 2024
The benefit of receiving treatment from female physicians was larger for female patients than it was for male patients.
EPA designates two ‘forever chemicals’ as hazardous
Apr 22, 2024
Two common PFAS “forever chemicals” have been deemed hazardous substances by the Environmental Protection Agency.
Computer prompts could reduce empiric antibiotic use for UTI
Apr 19, 2024
A 17.4% reduction was seen in empiric extended-spectrum days of therapy, with no increase in safety outcomes.
Gains in heart health only experienced by higher-income populations
Apr 19, 2024
The 10-year risk for cardiovascular disease remained stagnant at >8% for US adults with the lowest incomes in 1988 to 2018.
Burnout, poor staffing substantially contribute to nurses leaving healthcare
Apr 11, 2024
The authors say that the leading reasons nurses leave healthcare signal opportunities for employers to reattract an existing nurse workforce.
ACC: Gamification plus financial incentives boost physical activity
Apr 11, 2024
Greatest effect seen during both the 12-month intervention and at six-month follow-up among patients at high risk for cardiovascular events
Many older Americans get care outside of doctor’s office, poll finds
Apr 10, 2024
Most people aged 50 to 80 have embraced “doc-in-a-box” strip mall clinics and urgent care centers as a means of getting prompt medical care, a new poll has found.
EPA sets strict limit on PFAS ‘forever chemicals’ in US drinking water
Apr 10, 2024
The Environmental Protection Agency announced Wednesday that it has finalized a first-ever rule that will drastically lower the amount of PFAS, also known as “forever chemicals,” in the nation’s...
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.